One major point in the Warning letter was the reference to the fact that the HCT/P used was adipose tissue which is structural tissue. There are two major mistakes here by the FDA First of the tissue is lipoaspirate which like bone marrow aspirate is not structural tissue but MORE IMPORTANTLY the HCT/P is the SVFC and NOT the adipose tissue and is a cellular product